Vice President, Global Program Head - Immunology, Innovative Medicines

Who We Are:

Together, we’re on a mission to make good health more affordable and accessible, to help millions around the world enjoy healthier lives. It’s a mission that bonds our people across nearly 60 countries and a rich, diverse variety of nationalities and backgrounds. Working here means working with the world’s leading manufacturer of generic medicines, and the proud producer of many of the products on the World Health Organization’s Essential Medicines List. Today, at least 200 million people around the world take one of our medicines every single day. An amazing number, but we’re always looking for new ways to continue making a difference, and new people to make a difference with.

The Opportunity:

The Vice President, Global Program Head – Innovative Medicines is accountable for the overall strategy, leadership, and execution of a global development programs from early development through commercialization. Operating in a global matrix environment, this leader will deliver end-to-end strategic vision on a global scale, maximizing asset and portfolio value. Success in this role requires exceptional enterprise leadership, influence without authority, and the ability to navigate ambiguity, competing priorities, and complex stakeholder dynamics while driving decisive action and organizational alignment.

Position Locations: This is a hybrid position and can be based at one of our hubs: West Chester PA USA/Parsippany NJ USA, Netherlands, or Israel

Key Responsibilities:

Strategic Leadership & Enterprise Vision

• Set a bold, transformational asset vision anticipating future scientific, technological (e.g., AI, precision medicine), and market trends to increase program competitiveness.
• Embraces accountability for strategic direction, value creation, integrated development planning, and long-term lifecycle management of the asset.
• Synthesizes complex internal and external insights, including the external competitive landscape, to inform enterprise-level decisions and scenario planning, ensuring a future-ready strategy despite an ambiguous or evolving environment.

End-to-End Program Ownership & Delivery

• Owns full program lifecycle from preclinical stages through global approval and beyond, ensuring scientific rigor, regulatory readiness, and commercial differentiation.
• Leads the Global Program Team (GPT) through major program governance interactions, including the Innovative Development Committee; and helps represent the asset internally and externally, including global health authorities, advisory boards, and corporate partners.
• Develops a strong working relationship with all team members and functional area stakeholders.  Cultivates a high functioning partnership with the GPTD and with commercial co-leader (late phase development programs).

Stakeholder Leadership & External Engagement

• Shapes and aligns stakeholder expectations through transparent, evidence-based communication and inclusive decision-making.
• Builds and sustains trusted relationships with senior leaders, peers, team members, partners, external experts, and joint governance structures.

Global Program Team Leadership & Talent Development

• Leads and inspires multidisciplinary global program teams, driving high performance, accountability, and shared ownership of outcomes.
• Fosters a “project first” approach within the GPT. Works closely with project team members, inspiring a “can-do” approach. Fosters an environment of risk-taking and bold ideas.

Your Skills and Experience:

• Minimum 15 years of experience in pharmaceutical/biotechnology R&D with demonstrated leadership across early and late development.
• Proven track record leading large-scale global cross-functional matrix teams without authority, driving alignment and execution across multiple functions, and governance bodies
• Experience managing complex external partnerships, joint governance structures, and high-stakes program communication.
• Demonstrates deep scientific, clinical, regulatory, and commercial understanding across the development spectrum.
• Experience with lifecycle management and global submissions (NDA/BLA/MAA) is preferred.
• Doctoral degree (MD, PhD, PharmD) preferred.
• Experience with marketed products is preferred.
• Experience in Neuroscience and/or Immunology is preferred.

Competencies:

• Enterprise Leadership: Elevates organizational thinking beyond functional priorities; inspires followership.
• Strategic Agility: Anticipates shifts in science, market, and technology; adjusts strategy proactively.
• Influence Without Authority: Builds alignment across senior stakeholders, resolving conflict and enabling decisive progress.
• Evidence-Based Decision-Making: Synthesizes scientific, medical, and business insights to guide high-impact decisions.
• Execution Excellence: Ensures disciplined planning, operational rigor, and delivery of commitments.
• Communication Mastery: Adjusts tone, style, and depth for executive, scientific, regulatory, and patient-facing audiences.
• High-Performance Team Leadership: Develops, motivates, and elevates fellow team members; fosters accountability and growth.
• High Personal Accountability: The successful candidate will effectively assume accountability for their actions. He or she should be a results-oriented team player who leads by example, holds him/herself accountable for performance, and champions all aspects of assigned areas while remaining detail-oriented
• Leads with urgency: Proactively anticipates and responds to challenges and opportunities; works relentlessly to reduce “cycle” times and “white space”; “action-oriented” – does not wait for instructions.

How We’ll Take Care of You:

Already Working @Teva?

Teva’s Equal Employment Opportunity Commitment